Bratislava Statement: consensus recommendations for improving pancreatic cancer care
Pancreatic cancer is one of the most lethal tumours, and it is the fourth cause of cancer death in Europe. Despite its important public health impact, no effective treatments exist, nor are there high-visibility research efforts to improve care. This alarming situation is emblematic of a larger grou...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | ESMO Open |
Online Access: | https://esmoopen.bmj.com/content/5/6/e001051.full |
id |
doaj-c7fbab938e434aa7bc7935dad09e696d |
---|---|
record_format |
Article |
spelling |
doaj-c7fbab938e434aa7bc7935dad09e696d2021-04-02T20:44:57ZengElsevierESMO Open2059-70292020-12-015610.1136/esmoopen-2020-001051Bratislava Statement: consensus recommendations for improving pancreatic cancer carePamela Minicozzi0Alfredo Carrato1Núria Malats2Francesco Sclafani3Thomas Brunner4Joan Prades5Antonella Cardone6Cristina Coll-Ortega7Samuel De Luze8Pascal Garel9Maria E Goossens10Roberto Grilli11Meggan Harris12Marleen Louagie13Stefano Partelli14Silvia Pastorekova15Marius Petrulionis16Bozena Smolkova17Josep M Borras18London School of Hygiene & Tropical Medicine, London, UKPancreatic Cancer Europe, Brussels, BelgiumPancreatic Cancer Europe, Brussels, BelgiumDigestive Oncology Laboratory, Institut Jules Bordet, Bruxelles, BelgiumDepartment of Radiation Oncology, Otto von Guericke Universität Magdeburg, Magdeburg, Sachsen-Anhalt, GermanyCatalonian Cancer Strategy, Department of Health, Barcelona, SpainPancreatic Cancer Europe, Brussels, BelgiumCatalonian Cancer Strategy, Department of Health, Barcelona, SpainInstitut National du Cancer, Billancourt, Île-de-France, FranceEuropean Hospital and Healthcare Federation, Brussels, BelgiumCancer Centre–OD Public Health and Surveillance, Sciensano, Brussels, BelgiumAzienda USL-IRCCS of Reggio Emilia, Bologna, ItalyIndependent Researcher, Valencia, SpainBelgian National Institute for Health and Disability Insurance, Brussels, BelgiumUniversità Vita Salute San Raffaele, Milano, Lombardia, ItalyBiomedical Research Center, Slovak Academy of Sciences, Bratislava, SlovakiaVilnius University Hospital Santariskiu Klinikos, Vilnius, LithuaniaBiomedical Research Center, Slovak Academy of Sciences, Bratislava, SlovakiaCatalonian Cancer Strategy, Department of Health, Barcelona, SpainPancreatic cancer is one of the most lethal tumours, and it is the fourth cause of cancer death in Europe. Despite its important public health impact, no effective treatments exist, nor are there high-visibility research efforts to improve care. This alarming situation is emblematic of a larger group of cancer diseases, known as neglected cancers. To address the impact of these diseases, the European Commission-supported Innovative Partnership for Action Against Cancer launched a multi-stakeholder initiative to determine key steps that healthcare systems can rapidly implement to improve their response. A working group comprising 20 representatives from European medical societies, patient associations, cancer plan organisations and other relevant European healthcare stakeholders was organised. A consensus process based on the results of different studies, discussion of research outcomes, and development and endorsement of draft statements resulted in 22 consensus recommendations (the Bratislava Statement). The statement argues that substantial improvements can be achieved in patient outcomes by centralising pancreatic cancer care around state-of-the-art reference centres, staffed by expert multidisciplinary teams capable of providing high-quality care. This organisational model requires a specific care framework encompassing primary, palliative and survivorship care, and a policy environment prioritising the use of quality criteria and performance assessments as well as research investments dedicated to prevention, risk prediction, early detection and diagnosis. In order to address the challenges posed by neglected cancers in general and pancreatic cancer in particular, a specific control strategy tailored to this reality is required.https://esmoopen.bmj.com/content/5/6/e001051.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pamela Minicozzi Alfredo Carrato Núria Malats Francesco Sclafani Thomas Brunner Joan Prades Antonella Cardone Cristina Coll-Ortega Samuel De Luze Pascal Garel Maria E Goossens Roberto Grilli Meggan Harris Marleen Louagie Stefano Partelli Silvia Pastorekova Marius Petrulionis Bozena Smolkova Josep M Borras |
spellingShingle |
Pamela Minicozzi Alfredo Carrato Núria Malats Francesco Sclafani Thomas Brunner Joan Prades Antonella Cardone Cristina Coll-Ortega Samuel De Luze Pascal Garel Maria E Goossens Roberto Grilli Meggan Harris Marleen Louagie Stefano Partelli Silvia Pastorekova Marius Petrulionis Bozena Smolkova Josep M Borras Bratislava Statement: consensus recommendations for improving pancreatic cancer care ESMO Open |
author_facet |
Pamela Minicozzi Alfredo Carrato Núria Malats Francesco Sclafani Thomas Brunner Joan Prades Antonella Cardone Cristina Coll-Ortega Samuel De Luze Pascal Garel Maria E Goossens Roberto Grilli Meggan Harris Marleen Louagie Stefano Partelli Silvia Pastorekova Marius Petrulionis Bozena Smolkova Josep M Borras |
author_sort |
Pamela Minicozzi |
title |
Bratislava Statement: consensus recommendations for improving pancreatic cancer care |
title_short |
Bratislava Statement: consensus recommendations for improving pancreatic cancer care |
title_full |
Bratislava Statement: consensus recommendations for improving pancreatic cancer care |
title_fullStr |
Bratislava Statement: consensus recommendations for improving pancreatic cancer care |
title_full_unstemmed |
Bratislava Statement: consensus recommendations for improving pancreatic cancer care |
title_sort |
bratislava statement: consensus recommendations for improving pancreatic cancer care |
publisher |
Elsevier |
series |
ESMO Open |
issn |
2059-7029 |
publishDate |
2020-12-01 |
description |
Pancreatic cancer is one of the most lethal tumours, and it is the fourth cause of cancer death in Europe. Despite its important public health impact, no effective treatments exist, nor are there high-visibility research efforts to improve care. This alarming situation is emblematic of a larger group of cancer diseases, known as neglected cancers. To address the impact of these diseases, the European Commission-supported Innovative Partnership for Action Against Cancer launched a multi-stakeholder initiative to determine key steps that healthcare systems can rapidly implement to improve their response. A working group comprising 20 representatives from European medical societies, patient associations, cancer plan organisations and other relevant European healthcare stakeholders was organised. A consensus process based on the results of different studies, discussion of research outcomes, and development and endorsement of draft statements resulted in 22 consensus recommendations (the Bratislava Statement). The statement argues that substantial improvements can be achieved in patient outcomes by centralising pancreatic cancer care around state-of-the-art reference centres, staffed by expert multidisciplinary teams capable of providing high-quality care. This organisational model requires a specific care framework encompassing primary, palliative and survivorship care, and a policy environment prioritising the use of quality criteria and performance assessments as well as research investments dedicated to prevention, risk prediction, early detection and diagnosis. In order to address the challenges posed by neglected cancers in general and pancreatic cancer in particular, a specific control strategy tailored to this reality is required. |
url |
https://esmoopen.bmj.com/content/5/6/e001051.full |
work_keys_str_mv |
AT pamelaminicozzi bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT alfredocarrato bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT nuriamalats bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT francescosclafani bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT thomasbrunner bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT joanprades bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT antonellacardone bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT cristinacollortega bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT samueldeluze bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT pascalgarel bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT mariaegoossens bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT robertogrilli bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT megganharris bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT marleenlouagie bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT stefanopartelli bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT silviapastorekova bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT mariuspetrulionis bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT bozenasmolkova bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare AT josepmborras bratislavastatementconsensusrecommendationsforimprovingpancreaticcancercare |
_version_ |
1721546669970948096 |